Long-Term Results of Melphalan-Based Isolated Limb Perfusion With or Without Low-Dose TNF for In-Transit Melanoma Metastases

By Rossi Carlo  

Annals of Surgical Oncology, Vol. 17, Iss. 11, 2010-11 ,pp. : 3000-3007

Springer Publishing Company

Access to resources Recommend Favorite

Isolated Hepatic Perfusion with High-Dose Melphalan Results in Immediate Alterations in Tumor Gene Expression in Patients with Metastatic Ocular Melanoma

By Varghese Sheelu  

Annals of Surgical Oncology, Vol. 17, Iss. 7, 2010-07 ,pp. : 1870-1877

Springer Publishing Company

Access to resources Recommend Favorite

A Single Centre's 10 Year Experience With Isolated Limb Perfusion in the Treatment of Recurrent Malignant Melanoma of the Limb

By Lingam M.K.   Byrne D.S.   Aitchison T.   MacKie R.M.   McKay A.J.  

European Journal of Cancer, Vol. 32, Iss. 10, 1996-09 ,pp. : 1668-1673

Elsevier

Access to resources Recommend Favorite

A Comparison of Dosimetric Methods in Isolated Limb Perfusion with Melphalan for Malignant Melanoma of the Lower Extremity

By Byrne D.S.   McKay A.J.   Blackie R.   MacKie R.M.  

European Journal of Cancer, Vol. 32, Iss. 12, 1996-11 ,pp. : 2082-2087

Elsevier

Access to resources Recommend Favorite

Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities

By Boesch Cedric E.   Meyer Thomas   Waschke Lena   Merkel Susanne   Goehl Jonas   Hohenberger Werner   Knorr Christian  

International Journal of Hyperthermia, Vol. 26, Iss. 1, 2010-06 ,pp. : 16-20

Informa Healthcare

Access to resources Recommend Favorite